Biohit Oyj Correlations
BIOBV Stock | EUR 2.33 0.00 0.00% |
The current 90-days correlation between Biohit Oyj B and Sampo Oyj A is -0.08 (i.e., Good diversification). The correlation of Biohit Oyj is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Biohit |
The ability to find closely correlated positions to Biohit Oyj could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biohit Oyj when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biohit Oyj - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biohit Oyj B to buy it.
Moving against Biohit Stock
Related Correlations Analysis
0.69 | 0.65 | 0.8 | -0.06 | SAMPO | ||
0.69 | 0.88 | 0.82 | -0.4 | UPM | ||
0.65 | 0.88 | 0.84 | -0.44 | WRT1V | ||
0.8 | 0.82 | 0.84 | -0.28 | ELISA | ||
-0.06 | -0.4 | -0.44 | -0.28 | KESKOB | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Biohit Stock performing well and Biohit Oyj Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Biohit Oyj's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
SAMPO | 0.63 | (0.08) | 0.00 | (0.39) | 0.00 | 1.08 | 3.86 | |||
UPM | 1.19 | (0.15) | 0.00 | (1.93) | 0.00 | 2.17 | 6.42 | |||
WRT1V | 1.40 | (0.20) | 0.00 | 1.51 | 0.00 | 2.59 | 16.19 | |||
ELISA | 0.78 | (0.19) | 0.00 | (0.54) | 0.00 | 1.36 | 6.30 | |||
KESKOB | 0.79 | 0.02 | (0.03) | (0.04) | 1.16 | 1.01 | 14.88 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Biohit Oyj without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Idea Breakdown Now
Idea BreakdownAnalyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
All Next | Launch Module |
Biohit Oyj Corporate Management
Elected by the shareholders, the Biohit Oyj's board of directors comprises two types of representatives: Biohit Oyj inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biohit. The board's role is to monitor Biohit Oyj's management team and ensure that shareholders' interests are well served. Biohit Oyj's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biohit Oyj's outside directors are responsible for providing unbiased perspectives on the board's policies.
Panu Hendolin | Head of Research and Development, Member of the Management Team | Profile | |
Jussi Hahtela | Chief Officer | Profile | |
Yulia Kubacheva | Head Russia | Profile | |
Jussi Sorvo | Chief Officer | Profile | |
Pr MD | Deputy Founder | Profile |